Search

The Cystic Fibrosis Foundation has awarded $15 Million to 33 organizations studying how to improve outcomes for cystic fibrosis patients battling infections, and three are phage therapy-based approaches! One is for research into phages that

Elizabeth Svoboda wrote a Nature Outlook article diving into the current state of phage therapy options for cystic fibrosis patients, and initiatives working to make this a reality. We're thrilled to see Phage Directory highlighted in this

Ella Balasa, one of our guest writers and volunteers, and former phage therapy recipient, has written about what it's like being at high risk for COVID-19; a very sobering read (though it ends on a positive note!).

Ella Balasa, one of our guest writers and volunteers, and former phage therapy recipient, has written about what it's like being at high risk for COVID-19; a very sobering read (though it ends on a positive note!).

The Cystic Fibrosis Foundation announced they will provide up to $5M to support Armata Pharmaceuticals in conducting a Phase 1b/2 clinical trial to test the safety and tolerability of phage therapy in Pseudomonas aeruginosa infections in pe

Elizabeth Burgener (Stanford University) and colleagues published a new preprint on methods for extracting and detecting phage DNA from CF patient sputum.

Elizabeth Burgener (Stanford University) and colleagues published a new preprint on methods for extracting and detecting phage DNA from CF patient sputum.

The Cystic Fibrosis Foundation announced they will provide up to $5M to support Armata Pharmaceuticals in conducting a Phase 1b/2 clinical trial to test the safety and tolerability of phage therapy in Pseudomonas aeruginosa infections in pe

Ella Balasa, who received phage therapy in 2019 (which she wrote about in Capsid & Tail earlier this year), has her own column in Cystic Fibrosis News Today called This Lung Life. Her newest article describes her participation in an FDA pan

Ella Balasa, who received phage therapy in 2019 (which she wrote about in Capsid & Tail earlier this year), has her own column in Cystic Fibrosis News Today called This Lung Life. Her newest article describes her participation in an FDA pan

Diane Shader Smith wrote a beautiful article commemorating the two-year anniversary of her daughter Mallory’s passing. Mallory passed away due to drug-resistant Burkholderia and cystic fibrosis. Diane remarks that Mallory's legacy lives on

Diane Shader Smith wrote a beautiful article commemorating the two-year anniversary of her daughter Mallory’s passing. Mallory passed away due to drug-resistant Burkholderia and cystic fibrosis. Diane remarks that Mallory's legacy lives on

We are urgently seeking Pandoraea pulmonicola phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By receiving the strain and testing your phages - By receiving the strain and using it to search for new phages a

We are urgently seeking Burkholderia cenocepacia phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages -

The Cystic Fibrosis Foundation, a world-leading non-profit that drives CF research and development, has teamed up with CARB-X, a global partnership investing in antibacterial innovation, in pursuit of a new Infection Research Initiative. Th

A new paper by Mohammad Tariq and colleagues at the University of Northumbria describes induction of temperate P. aeruginosa phages isolated from patients with cystic fibrosis or bronchiectasis. The more advanced the disease, the broader ho

A new paper by Mohammad Tariq and colleagues at the University of Northumbria describes induction of temperate P. aeruginosa phages isolated from patients with cystic fibrosis or bronchiectasis. The more advanced the disease, the broader ho

The Cystic Fibrosis Foundation, a world-leading non-profit that drives CF research and development, has teamed up with CARB-X, a global partnership investing in antibacterial innovation, in pursuit of a new Infection Research Initiative. Th

The same group that brought us the fascinating study on filamentous phage Pf's influence on P. aeruginosa virulence has published another study on the same phage. This time, they describe Pf prevalence (high) and implications (increased ant

The same group that brought us the fascinating study on filamentous phage Pf's influence on P. aeruginosa virulence has published another study on the same phage. This time, they describe Pf prevalence (high) and implications (increased ant